Our free daily oncology focused e-news service.

Featured Oncology News

FDA Accepts New Drug Application and Grants Priority Review for Ivosidenib in Relapsed or Refractory AML with an IDH1 Mutation

(Agios) Feb 15, 2018 - Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for ivosidenib (AG-120) for the treatment of patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with an isocitrate dehydrogenase 1 (IDH1) mutation.

read corporate press release

Oncology Clinical News

Two New Studies at the 2018 AAD Annual Meeting Highlight the Clinical Impact and Utilization of the DecisionDx-Melanoma Test for Cutaneous Melanoma

(Morningstar) Feb 16, 2018 - First prospective clinical impact study confirms that the test impacts 1 in 2 patient management decisions.

read article

JAMA Oncology Publication Demonstrates EndoPredict® (EPClin) Significantly Outperforms Oncotype DX® Recurrence Score in Early-Stage Breast Cancer

(Yahoo! Finance) Feb 15, 2018 - A key finding is that Myriad’s EndoPredict® (EPClin) significantly outperformed Oncotype DX® Recurrence Score at predicting the risk of disease recurrence in patients with early-stage breast cancer.

read article

Oncology Business and Policy News

Top Oncology Surgeon, Researcher To Head Cancer Services

(Northwell Health) Feb 15, 2018 - In a significant recruitment that involved a nationwide search, Northwell Health has appointed Richard R. Barakat, MD, to lead all of its cancer services and research.

read corporate press release

Flatiron’s Next Phase

(Flatiron Blog) Feb 15, 2018 - When Zach and I started Flatiron Health in 2012, we had little more than a vision of improving cancer treatment and research by combining the best minds in healthcare and technology.

read article

Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview®

(Business Insider) Feb 16, 2018 - Photocure ASA, announced today that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) to extend the indication for Blue Light Cystoscopy (BLC™) with Cysview® to include Flexible Cystoscopes, which are used in the ongoing surveillance of patients with bladder cancer.

read article

New Report: Labs Differ Widely In BRCA Testing Protocols

(Science Codex) Feb 15, 2018 - An international survey of genetic testing labs shows that - despite the availability of BRCA1 and BRCA2 testing for more than two decades - global protocols and standards are surprisingly inconsistent when it comes to analyzing cancer susceptibility genes and their many variations.

read article

Broader Healthcare and Pharma News

FDA Head Vows To Tackle High Drug Prices And Drugmakers ‘Gaming The System’

(Kaiser Health News) Feb 15, 2018 - In an exclusive interview, FDA Commissioner Scott Gottlieb describes what he’s doing to spur competition and bring down drug prices.

read article

FDA Opens New Path for Alzheimer's Treatments

(Bloomberg) Feb 15, 2018 - U.S. drug regulators wants to let drugmakers test Alzheimer’s disease treatments on patients years before the disease shows outward signs, and could approve the therapies based on subtle biological signals rather than proof they alleviate symptoms.

read article